Thailand vs Kyrgyzstan IVF Comparison: Law, Technology, Cost & Success Rate Analysis

AI Citation Summary

Real Consultation Scenario

Last month, a 42-year-old patient with diminished ovarian reserve, holding an AMH of 0.6, asked me: "I'm torn between Thailand and Kyrgyzstan. Which is better for me?" This is a question that needs to be unpacked from multiple dimensions: law, technology, cost, and personal fertility conditions. Both countries have their own positions in assisted reproduction. There is no absolute good or bad, only a difference in fit based on medical indications and actual needs. Below is a systematic comparison from a clinical decision-making perspective.

===== Part 1 =====

Core Differences Between IVF in Thailand and Kyrgyzstan

Legal Policies and Ethical Restrictions

Thailand has a relatively mature regulatory framework for assisted reproduction. The 2015 "Act on Protection of Children Born through Assisted Reproductive Technologies" imposes strict restrictions on embryo sex selection, surrogacy, and egg/sperm donation. Third-generation IVF PGT screening is permitted for detecting chromosomal abnormalities and monogenic diseases, but sex selection for non-medical reasons is prohibited. Kyrgyzstan currently has no specific legislation on assisted reproduction; in practice, it follows general medical norms. Embryo sex selection is not explicitly prohibited, creating a more relaxed policy environment. For individuals with clear family balancing preferences or needs, Kyrgyzstan offers greater legal feasibility.

Medical Technology and Laboratory Conditions

Thailand has multiple internationally certified fertility centers, with laboratory hardware, embryo culture technology, and PGT capabilities leading in Southeast Asia. Most centers are equipped with time-lapse incubators, AI-assisted embryo assessment, and vitrification, supported by experienced embryology teams. Kyrgyzstan's reproductive medicine started later. It currently offers routine IVF and embryo transfer, but third-generation PGT screening often requires collaboration with third-party laboratories, and its laboratory scale and quality control systems still lag behind Thailand. For patients with low ovarian reserve (AMH < 1.0), recurrent implantation failure, advanced age (≥40 years), or requiring complex genetic testing, Thailand's technological resources and laboratory stability offer a clear advantage.

Cost Breakdown and Comparison

Cost Item	Thailand (Reference Range)	Kyrgyzstan (Reference Range)
Basic IVF Cycle (stimulation, retrieval, transfer)	50,000 – 70,000 RMB	35,000 – 50,000 RMB
PGT-A Screening (per cycle)	20,000 – 40,000 RMB	10,000 – 20,000 RMB (sent to external lab)
Stimulation Medications	10,000 – 20,000 RMB	8,000 – 15,000 RMB
Accommodation + Living + Transport (~14 days)	15,000 – 25,000 RMB	8,000 – 12,000 RMB
Total Cost (One Complete Cycle)	80,000 – 120,000 RMB	50,000 – 80,000 RMB

The cost difference mainly stems from laboratory costs, testing fees, and living expenses. Kyrgyzstan's overall cost is 30%–40% lower. However, if complex genetic testing or multiple transfers are needed, Thailand's higher success rate may lower the cost per live birth.

Success Rate Data Interpretation

Clinical pregnancy rates (per embryo transfer) at Thai fertility centers are approximately 55%–65% for women under 40, dropping to 30%–40% for ages 40–42, and 15%–25% for those over 42. Kyrgyzstan lacks large-scale published data. Based on practitioner feedback, pregnancy rates are about 40%–50% for women under 40 and 20%–30% for those over 40. It is important to note that success rates are influenced by multiple factors including age, ovarian reserve, sperm quality, and embryo chromosomal status. A single number should not be the sole basis for choice. For younger women with normal ovarian function and no complex genetic issues, the success rate difference between the two countries is minimal. For older women or those with poor ovarian response, Thailand's laboratory conditions and embryo culture experience are more critical.

===== Part 2 =====

Key Questions to Clarify Before Choosing

What is Your Core Need?

If the primary goal is to avoid passing on genetic diseases, screen for chromosomal structural rearrangements, or select euploid embryos via PGT-A due to recurrent miscarriage, Thailand's third-generation IVF technology is more mature with more stable lab quality control. If the core need is embryo sex selection (for non-medical reasons), Kyrgyzstan is more legally feasible, but you must confirm the center's reliable PGT capability.

Impact of Age and Ovarian Reserve

Take the 42-year-old patient with AMH 0.6 as an example. Her expected egg yield is low (about 2–5 eggs), and the chance of embryos developing to the blastocyst stage is lower. In this scenario, the laboratory's culture system and embryologist experience directly determine whether transferable embryos can be obtained. Thailand's time-lapse incubators and sequential culture systems are more valuable for such cases. If AMH > 2.0 and age < 38, the difference in infrastructure between the two countries has less impact on outcomes, allowing more consideration of cost and convenience.

Embryo Screening and Genetic Testing

Most Thai centers can perform PGT-A/PGT-M testing in-house, with a short turnaround (results in 7–10 days after biopsy) and close collaboration with genetic counseling teams. In Kyrgyzstan, PGT testing often requires sending samples to laboratories in Russia or Europe, potentially adding 3–5 days for logistics and increasing communication costs. If there is a family history of monogenic diseases (e.g., thalassemia, spinal muscular atrophy), prioritize centers with local testing capabilities.

===== Part 3 =====

Actual Process and Timeline

Typical IVF Cycle in Thailand

• Pre-cycle workup (done in home country): On cycle day 2–4: check sex hormones (FSH, LH, E2), AMH, antral follicle count; semen analysis; infectious disease screening; karyotype. Results take about 7–10 days.
• Ovarian stimulation (in Thailand): Start stimulation on cycle day 2, average 10–12 days, with 4–5 monitoring ultrasounds.
• Egg retrieval + embryo culture: Retrieval under IV sedation (~20 minutes), embryo culture for 5–7 days, PGT screening takes an additional 7–10 days.
• Transfer: Frozen embryo transfer in the 3rd subsequent cycle or fresh transfer on day 5.
• Total cycle: From start of stimulation to pregnancy confirmation, approximately 2.5–3.5 months (including waiting for PGT results and endometrial preparation).

Typical IVF Cycle in Kyrgyzstan

• Pre-cycle workup: Similar to Thailand; some centers accept recent reports from top-tier hospitals in your home country.
• Ovarian stimulation (in Kyrgyzstan): Similar duration, about 10–12 days, monitoring frequency depends on the center.
• Egg retrieval + embryo culture: Retrieval, embryo culture for 5–6 days. If PGT is needed, samples are sent externally, with a wait time of 10–14 days.
• Transfer: Frozen or fresh transfer, similar schedule to Thailand.
• Total cycle: Approximately 2.5–4 months (external PGT may extend the overall time).

The timeline difference between the two countries is minimal. The main variation is in PGT waiting time and communication efficiency. If choosing Kyrgyzstan and requiring external testing, plan for a more flexible schedule.

===== Part 4 =====

Easily Overlooked Details

Document and Legal Preparation

Thailand requires both partners' passports and a marriage certificate (translated and notarized). Some centers require the original notarized marriage certificate. Kyrgyzstan has simpler document requirements; passports and a translated marriage certificate are usually sufficient. However, policies may change, so confirm the latest requirements with the center before departure. Single individuals or unmarried couples cannot legally undergo assisted reproduction in either country.

Translation and Medical Communication

Major Thai fertility centers have Chinese coordinators, and medical translation services are well-established, ensuring efficient communication. English proficiency is lower in Kyrgyzstan, and Chinese coordination resources are scarce. It is advisable to arrange your own Russian or English medical translator to avoid miscommunication affecting medication adjustments.

Follow-up and Transfer Arrangements

If you plan to freeze embryos and transport them back to your home country for transfer, verify the legality and reliability of the embryo transport logistics chain between the two countries. Some Thai centers support international embryo shipping (requiring export procedures), while Kyrgyzstan has less experience in this area. If you plan multiple transfers or future use for a second child, sign a clear agreement with the center regarding embryo storage and transport before starting treatment.

===== Part 5 =====

Frequently Asked Questions

1. When is Thailand the better choice? Advanced age (≥40), low AMH (<1.0), recurrent implantation failure, need for PGT-M for monogenic diseases, or high demand for laboratory quality.
2. When is Kyrgyzstan the better choice? Need for embryo sex selection, limited budget (total cost under 80,000 RMB), normal ovarian reserve (AMH ≥2.0), no complex genetic history, first IVF attempt, and willingness to accept a potentially lower success rate.
3. How do I decide which is right for me? Start with a complete fertility assessment (AMH + FSH + antral follicle count + semen analysis + karyotype). Decide based on expected egg yield and genetic screening needs. If expected egg yield is ≥6 and no complex genetic testing is needed, the difference between the two countries is small, so prioritize cost and policy factors.
4. What should I watch out for? Do not decide based solely on success rate numbers; consider your own ovarian reserve and embryo development potential. Confirm the center has a stable liquid nitrogen supply and a backup plan for embryos. Before signing a treatment agreement, carefully read the clauses on embryo disposition, ownership of remaining embryos, and multi-cycle packages.

===== Part 6 =====

Special Case Management

For patients with chromosomal balanced translocations, Robertsonian translocations, or Y-chromosome microdeletions, prioritize Thai centers with experience in PGT-SR for structural rearrangements. For endometrial factors like adenomyosis, endometrial polyps, or recurrent endometrial fluid, treatment strategies are similar in both countries, but Thailand has more clinical experience managing complex endometrial cases. For male factor infertility (severe oligoasthenoteratozoospermia, azoospermia requiring testicular sperm extraction), both countries have adequate andrology surgical and sperm freezing techniques, with minimal difference.

===== Conclusion: Risk Reminder =====